Pyratine Group

Pyratine Group is a dermatology-focused pharmaceutical company that develops and markets medical-grade skincare products for inflammatory skin conditions and aesthetic rejuvenation. The company's technology is centered on second-generation cytokinins, specifically the small molecule furfuryl tetrahydropyranyladenine, which acts as a plant growth regulator with significant anti-inflammatory and anti-aging properties in human skin. Its flagship commercial products, Pyratine-XR and Pyratine-6, are clinically proven to treat conditions such as rosacea, melasma, and solar damage by reducing redness and improving skin barrier function. Unlike traditional retinoids or aggressive topical treatments, Pyratine's formulations are designed to be non-irritating, making them suitable for patients with highly sensitive skin. The company's products are primarily distributed through professional channels, including dermatologists, plastic surgeons, and medical spas.